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Abstract
Background: The impact of atopic dermatitis (AD) on children’s quality of life (QoL) in US and European countries
is relatively well known, though rarely evaluated in the Italian population. Moreover, the association between child
age and QoL has not been enough investigated, even though few studies detected a worse QoL in youngest AD
children. The aim of the study was to evaluate the QoL in an Italian sample of atopic children and their families,
also exploring a possible association with child age.
Methods: 60 AD children aged between 1-12 years and their mothers completed specific QoL questionnaires
(IDQoL/CDLQI, DFI) and a clinician completed a measure of AD severity (SCORAD).
Results: AD severity (Objective SCORAD) significantly correlated with QoL measures. Severe AD children showed
higher IDQoL/CDLQI and DFI scores compared to mild and moderate AD groups (P = 0.006 and P < 0.0005,
respectively), but only DFI scores differed in these last two conditions (P = 0.014). DFI scores negatively correlated
with children’sa g e( P = 0.046), but did not differ when considering child age ranges. Multiple linear regression
analyses revealed a significant association between Objective SCORAD and QoL measures.
Conclusions: A strong association between severe AD and poor QoL, both in children and mothers, was found in
the Italian sample, in line with the international literature. Family’s QoL scores were sensitively related to AD
severity, more than the child’s QoL, emphasising that the disease has a deep impact on the family. A significant
association between age and QoL was only partially found and needs further investigation.
Background
Atopic dermatitis (AD), also known as atopic eczema, is
one of the most common chronic inflammatory skin dis-
ease which occurs during childhood, affecting 10-20% of
children in Europe [1], and 17% of children in the United
States [2]. Time trends in atopy have shown a substantial
increase since the early 1960s and there is evidence of
consistent associations of these disorders with a Western
lifestyle [3].
Usually childhood AD onsets in the first five years of
life, with about 60% of cases appearing within the first
year, frequently between 0 and 6 months [4].
Adverse consequences of this disorder on children, like
distress, irritability, behavioural problems and sleep dys-
functions, have been reported in many previously pub-
lished articles [5-8]. Besides, negative influences have
been observed in families, such as frustration, feelings of
inadequacy about their role as parents, concerns, fears
about the disease, self-blame and disappointments
[4,7,9-14].
Recently, the detection of these adverse consequences
have led to estimate the AD impact on the young patient’s
Quality of Life (QoL) [12,15-19], putting in evidence how
a bad skin condition is frequently associated to a poorer
QoL.
QoL is a wide concept, influenced by physical health,
psychological state, level of independence and social
relations. The World Health Organization (WHO) has
tried to give quality of life (QOL) an exact definition:
“The individual’s perception of his position in life in the
context of culture and value systems in which he lives
and in relation to his goals, expectations, standards and
concerns” [20].
In medicine, attempts to construct methods for measur-
ing QOL have primarily focused on individuals with
chronic diseases with elevated costs of care and treatment,
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patients. A recent study [6] found that atopic children had
a worse QoL than children affected by other chronic dis-
eases (like, for example, naevi, acne, alopecia, diabetes,
psoriasis, asthma, cystic fibrosis, generalised eczema),
except cerebral palsy. Moreover, some studies evaluated
the association between child’sa g ea n dQ o L ,w h e r ea
major impact was observed in children of youngest age
[21,22] and their families [21].
While several studies have explored prevalence of AD
and related QoL in childhood, in USA and European
countries, to our knowledge few published studies have
analysed these aspects in Italian children [8,23,24].
The present study is a cross-sectional analysis, the aim
of which was to investigate the impact of AD on the QoL
of an Italian sample of atopic children and their families.
T h ee x p e c t e dr e s u l ti st of i n da na s s o c i a t i o nb e t w e e na
bad skin condition and a poorer QoL in children and their
parents. Secondly, the study aimed at exploring a possible




During the period March 2006-March 2007, all consecu-
tive AD patients (aged 1-12 years), attending the Derma-
tology Unit of M. Bufalini Hospital, Cesena (Italy), and
their mothers were considered eligible for the study and
therefore asked to participate.
AD patients were enrolled in the study during a routine
check-up in the Day-Hospital by a dermatologist, who
registered the clinical profile and calculated the objective
SCORAD, following the diagnostic criteria proposed by
Hanifin and Rajka [25]. A psychologist then presented the
research project to the mothers and their children; all sub-
jects who were asked to participate consented to take part
in the study and received the informed consent form and
a range of questionnaires to complete: Infants Dermatitis
Quality of Life Index (IDQoL), Children’sD e r m a t o l o g y
Life Quality Index (CDLQI), Dermatitis Family Impact
(DFI). All questionnaires were completed entirely. For
children aged 5-12 years, all the mothers completed the
DFI, while their children completed the CDLQI; younger
children’s mothers helped them in understanding and fill-
ing in the questionnaires. For the children aged 1-4 years
old, all mothers completed the DFI and the IDQoL.
Ethical approval (n° PR 887026) for the study was
obtained from the Hospital Ethics Committee.
Instruments
The instruments used in the study were:
The SCORAD [26], an index aimed at assessing AD
disease severity, where the higher the value the worse
the skin condition. Given that in literature [27] it has
been demonstrated that subjective symptoms do not
always correlate with disease severity and objective
assessment, and in relation to the recommendations by
Oranje et al. [27], we used the objective SCORAD,
instead of the SCORAD index, including extent and
intensity of the lesions, divided into three levels: < 15
mild, 15-40 moderate, > 40 severe [27].
A questionnaire including items on the main socio-
demographic characteristics.
T h eI n f a n t sD e r m a t i t i sQ u a l i t yo fL i f eI n d e x( I D Q o L
[28]; Italian validated version [29]), a disease-specific
measure for AD children between 0-4 years old, consist-
ing of 10 items concerning physical and social function-
ing and completed by the caregiver. A total score is
calculated (range 0-30), where higher scores represent a
poorer quality of life.
The Children’s Dermatology Life Quality Index
(CDLQI), a skin-related measure for children between
5-16 years old [30], consisting of 10 items on physical
and social functioning. The total score is between 0 and
30, where higher scores represent a poorer quality of
life.
The Dermatitis Family Impact questionnaire (DFI [13];
Italian validated version [29]), a 10-item scale measuring
the impact of AD on families with a child affected by the
disease, validated on a parents’ sample of AD children
aged 6 months-10 years old; the total score is calculated
a n dr a n g e sf r o m0t o3 0 ,w h e r e ,a g a i n ,t h eh i g h e rt h e
scores the poorer the quality of life.
Statistical analysis
Disease severity groups (mild, moderate, severe) were
defined in function of the objective SCORAD ranges;
patients were also classified in respect to specific age
groups (1-4, 5-7 and 8-12 years), which were chosen con-
sidering main developmental stages [31,32].
Qualitative variables were compared using Chi Square
test. Quantitative variables were analyzed first of all
using correlations (Pearson’s coefficient) and then using
ANOVA; specifically, HRQoL scores of participants in
different groups (according to AD severity levels and
age groups) were compared using ANOVA and per-
forming post hoc analyses with Tukeys Honestly Signifi-
cant Difference (HSD) test. A multiple regression was
performed in order to verify how much each variable
contributed to an explanation of the HRQoL scores. All
the following variables were included as predictors:
child’s gender, child’s age, Objective SCORAD, presence
of other allergies, caregiver’s age, marital status and
socio-economic level. Considering the low number of
subjects, the Enter method was chosen as the safest one
for the regression.
Statistical analyses were performed using the SPSS
Package for Windows software, version 17.0.
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Clinical characteristics of the study subjects
A total of 60 AD children (range 1-12 years; mean ± SD:
4.5 ± 3.3), including 30 females and 30 males, and their
60 mothers were recruited (range 25-50 years old; mean
± SD: 36.5 ± 5.8). Considering child age range, 37 chil-
dren (61.7%) were between 1 and 4 years old, 12 (20%)
between 5-7 years old and 11 (18.3%) between 8-12. In
16.7% of cases, the children also suffered from another
form of allergy, specifically cases of food allergy.
The majority of mothers were married (89.6%); most of
them had a permanent job (78.3%): 48.3% of them were
employees, 10% were self-employed and 20% worked in
other fields. According to Hollingshead criteria for socioe-
conomic status [33], women were classified as belonging
to one of three levels: low (27.1%), medium (60.4%) and
high (12.5%).
The mean Objective SCORAD score of the total sample
was 29.46 (± 16.31; range 3.5-74); no significant differ-
ences emerged in the mean objective SCORAD score
among the 3 children’sa g eg r o u p s( P = 0.93): children
between 1-4 years old had a score equal to 28.81 (± 14.85;
range 3.5-59.5), 5-7 year old children scored 30.49 (±
19.52; range 10-74), while 8-12 year old children scored
30.51 (± 18.78; range 8.8-62), (Table 1).
According to the categories of the objective SCORAD,
26.7% (16) of children showed a mild AD, 50% (30) a
moderate AD and 23.3% (14) a severe AD. The distribu-
tion of children across AD severity levels and age ranges
did not show any significant difference (c
2 = 0.559, df = 2
P = 0.97), (Table 1).
Also, the distribution of women in function of AD
severity and levels of socio-demographic variables did
not show significant differences (marital status: P = 0.25;
job: P = 0.34; socioeconomic status: P = 0.64).
Correlations among SCORAD and QoL measures
Correlations between Objective SCORAD and IDQoL/
C D L Q Ia n dD F Is c o r e sw e r ea l lstatistically significant,
even though moderate (r = 0.401, P =0 . 0 0 1a n dr =
0.414, P = 0.001, respectively). The correlation between
D F Ia n dI D Q o L / C D L Q Iw a sh i g ha n ds i g n i f i c a n t( r =
0.755, P < 0.0001). Child’s age negatively correlated with
DFI scores (r = -0.258, P = 0.046), but not with Objective
SCORAD (r = 0.098, P = 0.46) nor with IDQoL/CDLQI
(r = -0.119, P = 0.367).
Quality of life in relation to disease severity and child’s
age: comparisons among patient groups
IDQoL/CDLQI mean score in the total sample was 7.0 ±
5.21 (range 0-19). According to AD severity (Objective
SCORAD categories), IDQoL/CDLQI mean scores
appeared to be statistically different (P = 0.006): post hoc
analyses showed that the group with severe AD got a
higher score compared to the group with mild (P <
0.0005) and moderate AD (p = 0.038), but these last two
were not statistically different (P = 0.063; Table 2). When
considering child’s age range, differences in IDQoL/
CDLQI mean scores did not emerge among groups (P =
0.28; Table 2), not even when looking at the interaction
between AD severity and age range (P = 0.87).
DFI mean score in the total sample was 7.95 ± 6.21
(range 0-23). DFI mean scores as well differed in relation
to AD severity levels (P < 0.0005): the group with severe
AD showed a higher score compared to mild (P < 0.0005)
and moderate AD groups (P = 0.024) and the latter
was significantly higher than the mild group (P =0 . 0 1 4 ;
Table 2). Further significant differences did not emerge
when considering the child’s age range variable (P =0 . 0 7 4 ;
Table 2), nor when looking at “AD severity x child’sa g e ”
(P = 0.99).
Multiple linear regression of variables associated with
QoL measures
Using the Enter method, a significant model emerged
(P < 0.037), in which 22% (Adjusted R
2 = 0.217) of the
variance in IDQoL/CDLQI scores was explained by
Objective SCORAD (Beta coefficient = 0.479, P =
0.003), while all the other considered variables (sex,
child’s age, food allergies, mother’s age, marital status,
socio-economic level) did not significantly contribute to
the variance (Table 3).
Considering DFI scores as criterion variable, a significant
model emerged too (P < 0.008); again, Objective SCORAD
(Beta coefficient = 0.558, P < 0.0005) appeared to be the
Table 1 Objective SCORAD scores of 60 Children
AD Children
1-4 years (n = 37) 5-7 years (n = 12) 8-12 years (n = 11) p-value
Objective SCORAD (mean ± SD) 28.81 ± 14.85 30.49 ± 19.52 30.51 ± 18.78 0.93
Objective SCORAD severity -- -
Mild 10 (27.0) 3 (25.0) 3 (27.3) 0.97
Moderate 18 (48.6) 7 (58.3) 5 (45.5)
Severe 9 (24.3) 2 (16.7) 3 (27.3)
Figures in parentheses are percentages.
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(Adjusted R
2 = 0.308) (Table 3).
Discussion
To our knowledge, the current study is one of the few
published investigating QoL in an Italian sample of chil-
dren with atopic dermatitis.
Globally, the results showed a strong association
between QoL and disease severity, measured by Objec-
tive SCORAD, as already shown by international litera-
ture [16,17,19]. In fact, the study found that a bad skin
condition was significantly associated with a poorer
child QoL and with a significant worsening of family’s
QoL, evidencing how AD tends to affect the whole
family system and not only the individual patient. Com-
pared to a similar Italian study by Ricci et al. [8], includ-
ing 45 AD children aged between 3 months-7 years old,
our children and families’ QoL scores were noticeably
lower, but we must consider that a higher percentage of
severe AD was present in that sample (44.4% severe AD
children vs 23.3% in our study).
Looking into the details of our results and considering
both individual patients’ and families’ QoL scores, we
found some similarities and differences between the
two.
First of all, both QoL scores showed a moderate corre-
lation with Objective SCORAD, reporting very similar
coefficients; the scores also showed to be significantly
higher in severe AD children, compared to moderate
and mild AD conditions. That is, poorer QoL was
strictly associated to a more serious AD condition.
At the same time, differences between patients’ and
families’ perspectives emerged in relation to the follow-
ing aspects: while IDQOL/CDLQI scores were almost
equal in moderate and mild AD children, DFI scores
showed significant differences across all the 3 levels of
AD severity. This means that, in our sample, families’
QoL appeared to be noticeably affected by the intensity
and severity of the child disease, more than the indivi-
dual QoL. This aspect emphasises the main role played
by the family in the management of the disease and
should be more frequently kept in mind by clinicians.









IDQoL/CDLQI, mean ± SD 3.63 ± 4.03 7.0 ± 4.70 10.86 ± 5.02 0.006









IDQoL/CDLQI, mean ± SD 7.57 ± 5.02 6.83 ± 4.17 5.27 ± 6.77 0.28
DFI, mean ± SD 9.32 ± 6.37 6.08 ± 5.52 5.36 ± 5.41 0.074
Data are means ± SD
Table 3 Contribution of sociodemographic and clinical variables to QoL measures
Predictor Variables b values t p-value
IDQoL/CDLQI scores Sex -0.158 -1.067 0.294
Age -0.122 -0.624 0.537
Objective SCORAD 0.479 3.190 0.003
Food allergies -0.197 -1.242 0.223
Mother’s age 0.198 1.012 0.319
Marital status -0.195 -1.249 0.221
Socio-economic level 0.144 0.963 0.348
DFI scores Sex -0.197 -1.375 0.179
Age -0.174 -0.943 0.363
Objective SCORAD 0.558 3.958 0.000
Food allergies -0.205 -1.375 0.179
Mother’s age 0.013 0.071 0.944
Marital status -0.058 -0.398 0.694
Socio-economic level -0.001 -0.010 0.992
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CDLQI and DFI measures was that only the latter
appeared to be associated with child’sa g e .I nf a c t ,D F I
scores showed a negative correlation, even if weak, with
the child’s age: the parents of younger AD children
seemed to experience a poorer QoL, as already suggested
in the study by Ganemo et al. [21]. Anyway, given the
small size of our sample, the non significant P value
detected when considering DFI scores in relation to dif-
ferent age groups (P = 0.074) and the non-relevance of
the child’s age as predictor variable in regression analysis,
more investigations are needed.
The study has nevertheless some limitations. First of
all, difficulties in recruiting the subjects have resulted in
a limited sample size and a reduced number of consid-
ered variables and, because of this, further analyses on
wider Italian samples are needed in future to obtain
more statistically and clinically relevant data. Secondly,
we had no control group and this did not allow the com-
parison between our results and the QoL of healthy chil-
dren or children affected by other dermatological
diseases. In future studies, therefore, it would be relevant
to investigate whether in the Italian population the trends
shown in literature, where AD subjects exhibit poorer
QoL compared to control groups or other clinical groups,
are confirmed [6,19].
Conclusions
However, globally our data support the main clinical
implications derived from recent international studies on
QoL in atopic children; as underlined by Brenninkmeijer
et al. [34], “in cases of severe AD, dermatologists should
not only be attentive to the physical aspects but also to
the psychological and social aspects of AD. In conclusion,
we believe that in clinical care a systematic evaluation of
physical and psychosocial consequences in patients with
AD is warranted”. Understanding HRQoL in the patient
and his/her family might help professional operators to
improve their relationship with them and to facilitate the
management of treatment regimes. While early investiga-
tions tended to focus on socio-demographic and clinical
variables, recent studies have shown that there are multi-
ple factors which determine adherence, such as personal
perception of health status, coping style, worries, burden,
social reasons, motivation and side effects of treatments
[6,35]. Warschburger et al. [36] have underlined how par-
ental disease management is predicted by familial situa-
tion, personal well-being and severity of child disease.
For these reasons, it would be useful in future studies to
focus on psychosocial and psychological variables that
could affect families’ QoL, such as analysing whether there
is a substantial difference in mother and father’sp e r c e p -
tions, as investigated by Holm et al. [37] and Chernishov
[38], or if comorbidity with other parents’ diseases can
have some influence on their ability to provide the child
with adequate care. At the same time, studies examining
the effects of education programs on parental support
should be promoted [39].
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